Clinical trial
Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion
NCT00160199 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00160199 |
|---|---|
| Title | Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion |
| Official title | Evaluation of Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding in Subjects With Secondary Amenorrhea |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Secondary Amenorrhea |
| Intervention type | Drug |
| Interventions | PROMETRIUM® 300 mg, PROMETRIUM® 400 mg |
| Enrollment | 240 |
| Start date | Nov 1, 2004 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 7, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: